3Alexander JM, Biller BM, Bikkal H, et al. Clinically nonfunctioning pituitary tumors are monoclonal in origin [ J]. J Clin Invest, 1990, 86( 1 ): 336 - 340.
4Schulte HM, Oldfield EH, Allolio B, et al. Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis [ J]. J Clin Endocrinol Metab,1991, 73(6): 1302 - 1308.
5Finelli P, Giardino D, Rizzi N, et al. Non-random trisomies of chromosomes 5, 8 and 12 in the prolactinoma sub-type of pituitary adenomas: conventional cytogenetics and interphase FISH study [ J ].Int J Cancer, 2000, 86(3): 344 -350.
6Bello M J, de Campos JM, Kusak ME, et al. Chromosomal abnormalities in pituitary adenomas [ J ]. Cancer Genet Cytogenet,2001, 124(1): 76 -79.
7Ma W, Ikeda H, Yoshimoto T. Glinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas [J]. Cancer, 2002,95(2): 258 -266.
8Sanno N, Teramoto A, Osamura RY, et al. Pathology of pituitary tumors [J]. Neurosurg Clin N Am, 2003, 14(1): 25 -39.
9Osamura RY, Egashira N, Miyai S, et al. Molecular pathology of the pituitary. Development and functional differentiation of pituitary adenomas [J]. Front Horm Res, 2004, 32(1): 20-33.
10Seemann N, Kuhn D, Wrocklage C, et al. CDKN2A/p16 inactivation is related to pituitary adenoma type and size [J]. J Pathol, 2001, 193(4): 491 -497.
